CFO R&D Tax Survey: Results Overview

RCK Partners commissioned independent research conducted by Censuswide, surveying 254 CFOs from R&D-active SMEs that have claimed, or considered claiming, R&D tax relief within the last five years. The data was collected between 01/07/2026 - 07/07/2026.

Featured by The Times, this research explores the impact of recent R&D tax relief reforms on UK SMEs. As the first independent primary study of its kind, it provides a comprehensive assessment of how these changes are affecting innovative businesses across the UK.

July 2026, London.

* Censuswide is a member of the Market Research Society (MRS) and the British Polling Council (BPC), and a signatory of the Global Data Quality Pledge. They adhere to the MRS Code of Conduct and ESOMAR princip

Results summary

The research reveals that reforms introduced by HMRC to prevent abuse of the R&D tax relief scheme have led genuine innovators to cancel research, shelve projects, and reduce headcount amid growing uncertainty.

The findings revealed the following key statistics:

62
have reduced investment in R&D
35
have hired fewer technical staff than planned
20
have cancelled innovation projects
30
have taken out loans or other external finance to manage delays in receiving R&D tax relief
72
agree that the time HMRC takes to process and pay R&D claims makes the relief too unreliable to factor into their financial planning
71
say the current R&D tax relief scheme is less attractive for their business than it was four years ago
71
say the compliance burden associated with claiming R&D tax relief is disproportionate to the financial benefit

Q1. Which of the following, if any, has your business done as a direct consequence of changes to the UK's R&D tax relief regime? (Select all that apply)

View data for Q1
Q1. Which of the following, if any, has your business done as a direct consequence of changes to the UK's R&D tax relief regime? (Select all that apply)
Response Percentage
Hired fewer R&D or technical staff than planned 34.65%
Delayed an R&D project 28.74%
Reduced the scope of an R&D project 28.35%
Reduced offshore R&D teams or projects 24.02%
Decided not to submit an R&D tax relief claim 22.83%
Cancelled an R&D project 20.08%
None of the above 1.18%

Q2. Thinking specifically about changes to the UK's R&D tax relief regime, what impact, if any, have those changes had on your company's R&D investment decisions?

View data for Q2
Q2. Thinking specifically about changes to the UK's R&D tax relief regime, what impact, if any, have those changes had on your company's R&D investment decisions?
Response Percentage
They led us to reduce our investment in R&D (Net) 62.2%
They have had no material impact (Net) 25.2%
They led us to increase our investment in R&D (Net) 12.6%

Q3. In the last 5 years, what, if anything, have delays or uncertainty in receiving R&D tax relief payments led your business to do? (Select all that apply)

View data for Q3
Q3. In the last 5 years, what, if anything, have delays or uncertainty in receiving R&D tax relief payments led your business to do? (Select all that apply)
Response Percentage
Delay or reduce hiring 32.68%
Make redundancies or not replace staff who left 29.53%
Take out a loan or other external finance to cover the gap 29.53%
Delay payments to staff, suppliers or HMRC 26.77%
Draw on personal or director funds 25.98%
Delay or cancel investment in a project 13.39%
Delays and uncertainty haven't led my business to do anything in particular 1.18%
My business hasn't experienced any delays or uncertainties 0.39%

Q4. The UK now restricts R&D tax relief for most overseas R&D and development costs. How has your business responded, if at all?

View data for Q4
Q4. The UK now restricts R&D tax relief for most overseas R&D and development costs. How has your business responded, if at all?
Response Percentage
We kept our overseas arrangements and stopped claiming R&D tax relief altogether 48.03%
We considered relocating R&D/development work to the UK but decided against it 28.74%
We kept our overseas arrangements and still claim on reduced UK-only costs 16.14%
We have relocated (or are relocating) R&D/development work to the UK to keep qualifying 5.12%
N/A — my business has never had any overseas arrangements 1.97%

Q5. Why, if for any reason, did you decide against relocating that work in the UK? (Select all that apply)

*Those who decided against relocating that work in the UK

View data for Q5
Q5. Why, if for any reason, did you decide against relocating that work in the UK? (Select all that apply) — Those who decided against relocating that work in the UK.
Response Percentage
Overseas talent advantages outweighed the relief on offer 35.17%
Overseas cost outweighed the relief on offer 32.2%
The cut to R&D tax relief rates made onshoring uneconomic 31.78%
Our overseas work meets the exception for activity that cannot be done in the UK 31.78%
No reason 0.42%

Q6. If your business has been through an HMRC enquiry or compliance check into an R&D claim, what was the longest period you went without any substantive update from HMRC?

View data for Q6
Q6. If your business has been through an HMRC enquiry or compliance check into an R&D claim, what was the longest period you went without any substantive update from HMRC?
Response Percentage
Less than one month 0%
1–3 months 37.4%
4–6 months 59.06%
More than 6 months 0.79%

Q7. In the last five years, has HMRC ever paid out an R&D tax relief claim to your business and then later opened a compliance check seeking to reduce or recover that relief?

View data for Q7
Q7. In the last five years, has HMRC ever paid out an R&D tax relief claim to your business and then later opened a compliance check seeking to reduce or recover that relief?
Response Percentage
Yes 69.69%
No 21.26%
I don't know 9.06%

Q8. The time HMRC takes to process and pay R&D claims makes the relief too unreliable to factor into our financial planning. To what extent do you agree or disagree with this statement?

View data for Q8
Q8. The time HMRC takes to process and pay R&D claims makes the relief too unreliable to factor into our financial planning. To what extent do you agree or disagree with this statement?
Response Percentage
Strongly agree 27.95%
Somewhat agree 43.7%
Neither agree nor disagree 20.87%
Somewhat disagree 5.51%
Strongly disagree 1.97%

Q8 cont. The current R&D tax relief scheme is less attractive for our business than it was four years ago. To what extent do you agree or disagree with this statement?

View data: Scheme attractiveness
Q8 continued. The current R&D tax relief scheme is less attractive for our business than it was four years ago. To what extent do you agree or disagree with this statement?
Response Percentage
Strongly agree 31.1%
Somewhat agree 40.16%
Neither agree nor disagree 17.72%
Somewhat disagree 9.45%
Strongly disagree 1.57%

Q8 cont. The compliance burden associated with claiming R&D tax relief is disproportionate to the financial benefit. To what extent do you agree or disagree with this statement?

View data: Compliance burden
Q8 continued. The compliance burden associated with claiming R&D tax relief is disproportionate to the financial benefit. To what extent do you agree or disagree with this statement?
Response Percentage
Strongly agree 22.83%
Somewhat agree 48.43%
Neither agree nor disagree 19.69%
Somewhat disagree 7.87%
Strongly disagree 1.18%

Book your free audit